Fish & Richardson P.C.
Methods to reduce toxicities and to improve bioavailabilities of nanodrugs
Provided herein are methods for reducing clearance of nanotherapeutic agents from a subject, wherein the methods comprise administering a nutrition supplement to the subject prior to administration of the nanotherapeutic agent in the treatment of a disease. Methods for improving the bioavailability of the nanotherapeutic agent, methods of reducing the toxicity of the nanotherapeutic agent, and kits comprising the nutrition supplement and nanotherapeutic agent are also provided.
Carnegie Mellon University
A A A A A A A Y A A Y A
A61P A61K A23L A61K A61K A23V A23L Y10S A61K A61K Y10S A61K
inventional inventional inventional inventional inventional additional inventional additional inventional inventional additional inventional
Chien Qing Li
Ho Ye Liu